Researchers are ready to begin clinical trials of a medicine for a skin condition after completing all laboratory and animal tests.
State which group of people should receive the medicine first.
Describe how the dose should be changed during this first stage of the clinical trials.
The medicine is shown to be safe. State two things that should be found out when the medicine is then tested on people with the skin condition.
252 exam-style questions on AQA GCSE Biology 3.1 Communicable diseases, covering 3.1.1 Communicable (infectious) diseases, 3.1.2 Viral diseases, 3.1.3 Bacterial diseases, 3.1.4 Fungal diseases, 3.1.5 Protist diseases, 3.1.6 Human defence systems, 3.1.7 Vaccination, 3.1.8 Antibiotics and painkillers, and 3.1.9 Discovery and development of drugs. Each one has a worked solution and a mark scheme showing where the marks go.